Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
6 trials
Recent
Start date
Enrollment
Histamine H2 Antagonists
×
Clear all
Filters
1
NCT06305754
2026-03-13
MK-2870-009
Merck Sharp & Dohme LLC
Phase 3
Recruiting
520 enrolled
NCT06824467
2026-03-13
TroFuse-022
Merck Sharp & Dohme LLC
Phase 3
Recruiting
770 enrolled
NCT06788912
2026-03-10
MK-3475-01E
Merck Sharp & Dohme LLC
Phase 2
Recruiting
60 enrolled
NCT05319730
2026-03-02
MK-3475-06B
Merck Sharp & Dohme LLC
Phase 1/2
Recruiting
230 enrolled
NCT06789172
2025-09-05
INVOKE
Epkin
Phase 1
Recruiting
166 enrolled
NCT03050866
2021-08-20
CABA-V7
Erasmus Medical Center
Phase 2
Unknown
140 enrolled